Reduced CD34+, renal anemia, and adverse outcomes

American Heart Journal

Volumn 152, Issue 2, 2006, Pages

  Andreotti, Felicita ^a   Coluzzi, Giulio ^a   Cecchetti, Silvia ^a   Lavorgna, Alberto ^a   Marzo, Francesca ^a   Crea, Filippo ^a   Rumi, Carlo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANEMIA; CARDIOVASCULAR RISK; CD34 SELECTION; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; GLOMERULUS FILTRATION RATE; HAZARD ASSESSMENT; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOXIA; KIDNEY DYSFUNCTION; LETTER; PRIORITY JOURNAL; VASCULAR SURGERY;

ANEMIA; ANTIGENS, CD34; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33746266575     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.031     Document Type: Letter

References (5)

1. Astor B.C., Coresh J., Heiss G., et al. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 151 (2006) 492-500
2. Aicher A., Zeiher A.M., and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45 (2005) 321-325
3. Andreotti F., Crea F., and Conti E. Heart-kidney interactions in ischemic syndromes. Circulation 109 (2004) e31-e32
4. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
5. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007